Initial manifestation of parotid extra‑medullary myeloma in an HIV positive patient on anti‑retroviral therapy: A case report and review of the literature

Maharaj,Shivesh; Mungul,Sheetal

doi:10.3892/br.2020.1335

Initial manifestation of parotid extra‑medullary myeloma in an HIV positive patient on anti‑retroviral therapy: A case report and review of the literature

Authors:
- Shivesh Maharaj
- Sheetal Mungul
View Affiliations

Affiliations: Department of Otorhinolaryngology/Head and Neck Surgery, Charlotte Maxeke Johannesburg Academic Hospital, University of The Witwatersrand, Johannesburg 2193, South Africa
Published online on: July 22, 2020 https://doi.org/10.3892/br.2020.1335
Article Number: 28
Copyright: © Maharaj et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Multiple myeloma is a biologically diverse, malignant disease that involve plasma cells. Multiple myeloma is characterized by the unrestrained proliferation of monoclonal plasma cells within the bone marrow. In the present case report, the case of a human immunodeficiency virus (HIV) positive patient with an initial manifestation of extramedullary myeloma involving the parotid gland is described. The patient had been on antiretrovirals for the last two years. A Medline, Embase, Scopus and Google Scholar search was performed using the key words: ‘Parotid extramedullary myeloma AND HIV’ as part of the literature review. A 46‑year‑old female presented to our hospital with a 6‑month history of a painful mass on the left side of the face, involving the parotid area, with rapid growth in the preceding month. There was associated fever, body pains and difficulty opening the mouth. This resulted in difficulty in mastication and she also reported pain on swallowing. She did not notice any weakness of her face on the left side. She had no complaints regarding her eyes, such as visual disturbances, eye pain, or an inability to close the eye on the affected side. The patient was diagnosed with HIV infection 2 years prior, and had been on highly active antiretroviral therapy (HAART) since the diagnosis. There is no consensus regarding a treatment protocol for HIV positive patients on HAART and multiple myeloma. However, based on the clinical case report and a review of the relevant literature, the treatment should include high doses of a combination of chemotherapeutic agents. Although multiple myeloma is considered incurable, all patients should be started on treatment with the goal of preventing further complications.

View Figures

View References

1	Dezube BJ, Aboulafia DM and Pantanowitz L: Plasma cell disorders in HIV-infected patients: From benign gammopathy to multiple myeloma. AIDS Read. 14:372–374, 377-379. 2004.PubMed/NCBI
2	Roodman GD: Mechanisms of bone metastasis. N Engl J Med. 350:1655–1664. 2004.PubMed/NCBI View Article : Google Scholar
3	Longo DL and Anderson KC: Plasma cell disorders. In: Harrison's principles of internal medicine. Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL and Jameson JL (eds). 16th edition. McGraw-Hill, New York, NY, pp657-658, 2005.
4	Van Riet I: Homing mechanisms of myeloma cells. Pathol Biol (Paris). 47:98–108. 1999.PubMed/NCBI
5	The International Myeloma Working Group: Criteria for the classification monoclonal gammopathies, multiple myeloma and related disorders: A report of the international myeloma working group. Br J Haematol 121: 749-757, 2003.
6	Knobel D, Zouhair A, Tsang RW, Poortmans P, Belkacémi Y, Bolla M, Oner FD, Landmann C, Castelain B and Ozsahin M: Rare Cancer Network Prognostic factors in solitary plasmacytomas of the bone: A multicenter rare cancer network study. BMC Cancer. 6(118)2006.PubMed/NCBI View Article : Google Scholar
7	Ozsahin M, Tang RW, Poortmans P, Belkacémi Y, Bolla M, Dinçbas FO, Landmann C, Castelain B, Buijsen J, Curschmann J, et al: Outcomes and patterns of failure in solitary plasmacytoma: A multicenter rare cancer network study of 258 patients. Int J Radiat Oncol Biol Phys. 64:210–217. 2006.PubMed/NCBI View Article : Google Scholar
8	Micheletti AR, Macedo AC, Silva GB, Silva AC, Silva-Vergara ML, Murta EF and Adad SJ: Benign and malignant neoplasias in 261 necropsies for HIV-positive patients in the period of 1989 to 2008. Rev Inst Med Trop Sao Paulo. 53:309–314. 2011.PubMed/NCBI View Article : Google Scholar
9	Diamond T, Levy S, Day P, Barbagallo S, Manoharan A and Kwan YK: Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: Effects of glucocorticoid therapy and disease activity. Br J Haematol. 97:641–648. 1997.PubMed/NCBI View Article : Google Scholar
10	Nilsson-Ehle H, Holmdahl C, Suurküla M and Westin J: Bone scintigraphy in the diagnosis of skeletal involvement and metastatic calcification in multiple myeloma. Acta Med Scand. 211:427–432. 1982.PubMed/NCBI View Article : Google Scholar
11	Terpos E, Berenson J, Cook RJ, Lipton A and Coleman RE: Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease. Leukemia. 24:1043–1049. 2010.PubMed/NCBI View Article : Google Scholar
12	Vincent Rajkumar S: Multiple myeloma: 2014 Update on diagnosis, risk-stratification, and management. Am J Hematol. 89:999–1009. 2014.PubMed/NCBI View Article : Google Scholar
13	Grulich AE, Li Y, McDonald A, Correll PK, Law MG and Kaldor JM: Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS. 16:1155–1161. 2002.PubMed/NCBI View Article : Google Scholar
14	Ikezoe T, Saito T, Bandobashi K, Yang Y, Koeffler HP and Taguchi H: HIV-1 protease inhibitor induces growth arrest and apoptosis of human multiple myeloma cells via inactivation of signal transducer and activator of transcription 3 and extracellular signal-regulated kinase 1/2. Mol Cancer Ther. 3:473–479. 2004.PubMed/NCBI
15	Carraway H and Ambinder RF: Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus. Curr Opin Oncol. 14:543–545. 2002.PubMed/NCBI View Article : Google Scholar
16	Voelkerding KV, Sandhaus LM, Kim HC, Wilson J, Chittenden T, Levine AJ and Raska K Jr: Plasma cell malignancy in the acquired immune deficiency syndrome. Association with Epstein-Barr virus. Am J Clin Pathol. 92:222–228. 1989.PubMed/NCBI View Article : Google Scholar
17	de Camargo Moraes P, Thomaz LA, Montalli VA, Junqueira JL, Ribeiro CM and Oliveira LB: Extramedullary plasmacytoma diagnosed in an HIV-positive patient by an unusual clinical presentation. Case Rep Dent. 2016(6305173)2016.PubMed/NCBI View Article : Google Scholar
18	De Groot JJB, Webb MJ, Raubenheimer JE, Struwig MC and Louw VJ: Concomitant HIV infection in newly diagnosed multiple myeloma patients is hard to recognise and should be tested for routinely in areas of high endemicity. S Afr Med J. 107:781–787. 2017.PubMed/NCBI View Article : Google Scholar
19	Cauda R, Lucia MB, Marasca G, Rutella S, Petrucci MT, La Verde G and Gastaldi R: Beneficial effect of highly active antiretroviral therapy (HAART) in reducing both HIV viral load and monoclonal gammopathy. Eur J Haematol. 63:134–135. 1999.PubMed/NCBI View Article : Google Scholar
20	Gimeno LSE, Abella E, Perez-Vila E, Cervera M, Montero M, Gimenez MT, Knobel H and Besses C: Complete remission of smoldering myeloma in a HIV patient after highly antiretroviral therapy. Haematologica. 92 (Suppl 2)(S485)2007.